| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153162 | American Heart Journal | 2005 | 5 Pages |
Abstract
Clopidogrel has no impact on the effectiveness of myocardial reperfusion in patients with AMI treated routinely with stenting and abciximab. However, clopidogrel, administered as a 600-mg loading dose followed by 75 mg daily, is safe and at least as effective as the standard ticlopidine therapy in this subgroup of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Guido MD, PhD, FESC, Roberto MD, Angela MD, Gentian MD, Guia MD, Renato MD, Alberto MD, David MD,